These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Dutch Childhood Leukemia Study Group: early results of study ALL VI (1984-1988). Veerman AJ; Hählen K; Kamps WA; Vanleeuwen EF; de Vaan GA; Vanwering ER; Vanderdoes-Vandenberg A; Solbu G; Suciu S Haematol Blood Transfus; 1990; 33():473-7. PubMed ID: 2182439 [No Abstract] [Full Text] [Related]
11. Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90. Neth O; Seidemann K; Jansen P; Mann G; Tiemann M; Ludwig WD; Riehm H; Reiter A Med Pediatr Oncol; 2000 Jul; 35(1):20-7. PubMed ID: 10881003 [TBL] [Abstract][Full Text] [Related]
13. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group. Yamaji K; Okamoto T; Yokota S; Watanabe A; Horikoshi Y; Asami K; Kikuta A; Hyakuna N; Saikawa Y; Ueyama J; Watanabe T; Okada M; Taga T; Kanegane H; Kogawa K; Chin M; Iwai A; Matsushita T; Shimomura Y; Hori T; Tsurusawa M; Pediatr Blood Cancer; 2010 Dec; 55(7):1287-95. PubMed ID: 20535816 [TBL] [Abstract][Full Text] [Related]
14. Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience. Attarbaschi A; Mann G; Dworzak M; Urban C; Fink FM; Dieckmann K; Riehm H; Gadner H; Wien Klin Wochenschr; 2002 Feb; 114(4):148-57. PubMed ID: 12060981 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia]. Lu XT Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia. Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials. Harbott J; Ritterbach J; Ludwig WD; Bartram CR; Reiter A; Lampert F Recent Results Cancer Res; 1993; 131():123-32. PubMed ID: 8210633 [No Abstract] [Full Text] [Related]
18. [Outcome of childhood high-risk acute lymphoblastic leukemia treated with the ALL-BFM 95 protocol]. Ruan YS; Wu XD; Feng XQ; He YL; Zhang YM; Pei FY; Li CF Zhongguo Dang Dai Er Ke Za Zhi; 2015 Apr; 17(4):327-31. PubMed ID: 25919549 [TBL] [Abstract][Full Text] [Related]
19. [Experiences with modified BFM protocols in the treatment of children with acute lymphoblastic leukemia (ALL) in East Germany 1981-1991]. Zintl F; Malke H; Reimann M; Hermann J; Domula M; Dörffel W; Eggers G; Exadaktylos P; Hilgenfeld E; Kotte W Klin Padiatr; 1992; 204(4):221-9. PubMed ID: 1518257 [TBL] [Abstract][Full Text] [Related]
20. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. Stary J; Zimmermann M; Campbell M; Castillo L; Dibar E; Donska S; Gonzalez A; Izraeli S; Janic D; Jazbec J; Konja J; Kaiserova E; Kowalczyk J; Kovacs G; Li CK; Magyarosy E; Popa A; Stark B; Jabali Y; Trka J; Hrusak O; Riehm H; Masera G; Schrappe M J Clin Oncol; 2014 Jan; 32(3):174-84. PubMed ID: 24344215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]